Coverage by Xave Gregorio, Philippine Star
Merck & Co.'s breakthrough antiviral drug has been approved for emergency use in the Philippines. The Food and Drug Administration's greenlight for molnupiravir allows its adoption across the health system, when only 89 hospitals were previously allowed to administer it.
What it does: The pill was found in phase 3 clinical trials to prevent hospitalization for COVID-19 by 50% among those who have been infected.
